Scientists study leishmania infections to improve diagnosis and care
NCT ID NCT00344188
First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 10 times
Summary
This study looks at how leishmaniasis infections progress and respond to treatment. It involves up to 289 people aged 3 to 100 with known or suspected leishmaniasis. Researchers will collect blood and tissue samples to learn more about the disease and test different treatments. The goal is to better understand the infection and improve diagnostic tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LEISHMANIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heat treatment could bring leishmaniasis care to local clinics
- Leishmaniasis drug candidate tested in humans for first time – study halted early
- AI app aims to help frontline workers diagnose neglected skin diseases
- Scientists probe hidden causes of deadly parasite relapse in HIV patients
- New rapid test could speed up diagnosis of parasitic skin disease
- Generic antifungal drug shows promise in early comparison study